{
    "nctId": "NCT02904135",
    "briefTitle": "Collection of Circulating Tumor Cells From the Peripheral Blood of Metastatic Breast Cancer Patients",
    "officialTitle": "Collection of Circulating Tumor Cells From the Peripheral Blood of Metastatic Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Circulating Tumor Cells (CTCs)",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 141,
    "primaryOutcomeMeasure": "Overall survival(OS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Provision of signed written informed consent before enrollment into the study, ability to communicate with the investigators, and to understand and comply with the requirements of the study.\n2. Progressive and measurable metastatic breast cancer.\n3. Commencement of new anti-cancer chemotherapy or palliative care.\n4. ECOG performance status equal or less than grade 2.\n\nExclusion Criteria:\n\n1. Subject has received any investigational agent, not explicitly approved by MiCareo, within last one year.\n2. Subject being identified with any blood borne infectious disease.\n3. Subject has received anticancer chemotherapy within last one month. (not including hormone therapy, or target therapy)\n4. Pregnancy.",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}